News Alerts

08 Nov 2017 | 02:34 AM UTC

Burkina Faso: Nationwide dengue fever outbreak continues /update 2

Burkina Faso News Alert

Officials report 6699 suspected cases of dengue fever in Burkina Faso since beginning of 2017 (as of October 27) including 13 deaths; take precautions against mosquitoes

TIMEFRAME expected from 11/7/2017, 12:00 AM until 11/14/2017, 11:59 PM (Africa/Ouagadougou). COUNTRY/REGION Burkina Faso


At least 13 people have died in the ongoing dengue fever outbreak in Burkina Faso since the beginning of 2017, according to a statement made by the Ministry of Health on Friday, October 27. A total of 6699 suspected dengue cases have been reported this year, including 4428 probable cases. As part of efforts to control the outbreak, the government has implemented targeted mosquito spraying operations.

According to health officials, 12 of the country's 13 regions have been affected, although 64 percent of infections were reported in the Burkina Faso's central region, and in the capital city of Ouagadougou.


Dengue fever is transmitted via the Aedes aegypti mosquito. Symptoms include fever, headache, muscle and joint pain, fatigue, nausea, and rash. Dengue Hemorrhagic Fever (DHF) is a potentially deadly complication that is characterized by high fever, the enlargement of the liver, and hemorrhaging. The disease is mostly found in urban and semi-urban areas. Be aware that aspirin and non-steroidal anti-inflammatory drugs (ibuprofen) should be avoided as these drugs may worsen bleeding issues associated with the diseases. Patients may be given doses of acetaminophen (paracetamol). Dengue fever is particularly dangerous for those who have previously been infected with the disease.


Individuals in Burkina Faso are advised to take measures to protect themselves from mosquito bites - e.g., by wearing loose, covering clothing, using insect repellent, and sleeping in a screened-in or in an air-conditioned room - and to eliminate possible mosquito breeding grounds.


Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news